| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-11 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |